Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT02594748
Other study ID # BK2014011
Secondary ID
Status Suspended
Phase N/A
First received October 27, 2015
Last updated October 24, 2016
Start date July 2015
Est. completion date December 2019

Study information

Verified date October 2016
Source University of Turku
Contact n/a
Is FDA regulated No
Health authority China: Jiangsu Province Health Department
Study type Interventional

Clinical Trial Summary

The aims of the study are as follows:

- To improve self-management intention and behavior of patients with type 2 diabetes (T2 DM).

- To promote patients to make plans for their self-management and gradually integrate the self-management plan into their daily life.

- To improve resilience, well-being, fatigue and quality of life of patients with T2 DM

In order to achieve the aims, we have set the following objectives:

- To develop and apply self-management education program based on the extended theory of planned behavior.

- To evaluate the efficacy of the educational program:

1. Self-management education program delivered face to face (intervention group); (b) standard usual care (comparison group).


Description:

This study employs a quasi-experimental study design with an intervention and comparison group and follow-up of 3 months; there will be two measuring points (baseline and 3 months after the intervention) , and 9 measures.


Recruitment information / eligibility

Status Suspended
Enrollment 280
Est. completion date December 2019
Est. primary completion date June 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

1. age =18 years

2. duration of type 2 diabetes =3 months

3. without any severe complication and impaired cognition.

Exclusion criteria are:

1. severe physical handicap or mental illness

2. presence of other serious disease such as cancer and stroke.

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Self-management education
The intervention group will receive diabetes self-management education based on the idea of extended theory of planned behavior .
Routine care
They will attend the routine lecture in hospital sit and listen, usually 1-2 times during one week in hospital

Locations

Country Name City State
China The First People Hospital, Affiliated hospital of Nantong University Nantong Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
University of Turku

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in Audit of Diabetes Dependent Quality of Life at 3-month follow up. Measure the impact and important of 19 life domains. baseline and at three months. No
Secondary Change from baseline in Fatigue-14 scale at 3-month follow up. Baseline,3-month follow up. No
Secondary Change from baseline in Well-Being Index (WHO-5) Baseline,3-month follow up. No
Secondary Change from baseline in The Summary of Diabetes Self-Care Activities Measure at 3-month follow up. The scale include diet, exercise, medication, foot care and blood sugar monitoring Baseline,3-month follow up. No
Secondary Change from baseline in self-management planned behavior developed according to guideline at 3-month follow up. It is based on theory of planned behavior according to the following guideline. Including attitude, subjective norm, perceived behavior control, intention and behavior, action planning and coping planning.The response used likert 1-7 format. Baseline,3-month follow up. No
Secondary Change from baseline in Connor-Davidson Resilience Scale-10 at 3-month follow up. Baseline,3-month follow up. No
Secondary Change from baseline in HbA1c at 3-month follow up. HbA1c will be measured at outpatient of hospital. Baseline, 3-month follow up. No
Secondary Change from baseline in BMI at 3-month follow up. BMI will be measured at hospital and participants' home. Baseline,3-month follow up. No
Secondary Change from baseline in Blood sugar at 3-month follow up. Blood sugar will be measured at hospital and participants' home. Baseline,3-month follow up. No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2